Safety Study of DWP-450 (Botulinum Toxin, Type a) to Treat Glabellar Lines - EV-006
NCT02428608
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
570
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL:
DWP-450 (Botulinum purified neurotoxin, Type A)
Sponsor
Evolus, Inc.
Collaborators
[object Object]